GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:15657444
Citation |
Subramaniam, M, Gorny, G, Johnsen, SA, Monroe, DG, Evans, GL, Fraser, DG, Rickard, DJ, Rasmussen, K, van Deursen, JM, Turner, RT, Oursler, MJ and Spelsberg, TC (2005) TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol. Cell. Biol. 25:1191-9 |
---|---|
Abstract |
Transforming growth factor beta-inducible early gene 1 (TIEG1) is a member of the Kruppel-like transcription factor family. To understand the physiological role of TIEG1, we generated TIEG(-/-) (null) mice and found that the TIEG(-/-) mice had increased osteoblast numbers with no increased bone formation parameters. However, when calvarial osteoblasts (OBs) were isolated from neonatal TIEG(-/-) and TIEG(+/+) mice and cultured in vitro, the TIEG(-/-) cells displayed reduced expression of important OB differentiation markers. When the OBs were differentiated in vitro by treatment with bone morphogenic protein 2, the OBs from TIEG(+/+) calvaria displayed several mineralized nodules in culture, whereas those from TIEG(-/-) mice showed no nodules. To characterize the OBs' ability to support osteoclast differentiation, the OBs from TIEG(+/+) and TIEG(-/-) mice were cultured with marrow and spleen cells from TIEG(+/+) mice. Significantly fewer osteoclasts developed when TIEG(-/-) OBs were used to support osteoclast differentiation than when TIEG(+/+) OBs were used. Examination of gene expression in the TIEG(-/-) OBs revealed decreased RANKL and increased OPG expression compared to TIEG(+/+) OBs. The addition of RANKL to these cocultures only partially restored the ability of TIEG(-/-) OBs to support osteoclast differentiation, whereas M-CSF alone or combined with RANKL had no additional effect on osteoclast differentiation. We conclude from these data that TIEG1 expression in OBs is critical for both osteoblast-mediated mineralization and osteoblast support of osteoclast differentiation. |
Links |
PubMed PMC543998 Online version:10.1128/MCB.25.3.1191-1199.2005 |
Keywords |
Animals; Bone Marrow/metabolism; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins/metabolism; Calcification, Physiologic/physiology; Carrier Proteins/metabolism; Cell Differentiation/physiology; Cell Proliferation; Coculture Techniques; DNA-Binding Proteins/genetics; DNA-Binding Proteins/metabolism; Glycoproteins/metabolism; Membrane Glycoproteins/metabolism; Mice; Mice, Knockout; Osteoblasts/cytology; Osteoblasts/metabolism; Osteoclasts/cytology; Osteoclasts/metabolism; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear/metabolism; Receptors, Tumor Necrosis Factor; Spleen/cytology; Spleen/metabolism; Transcription Factors/genetics; Transcription Factors/metabolism; Transforming Growth Factor beta/metabolism |
edit table |
Significance
Annotations
Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
---|---|---|---|---|---|---|---|---|
edit table |
See also
References
See Help:References for how to manage references in GONUTS.